Quantbot Technologies’s Alder Biopharmaceuticals ALDR Stock Holding History

Quantbot Technologies’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-300	Closed	-$5K	–	1742
2019 Q3	$5K	Buy	+300	New	+$3.43K	﹤0.01%	1210
2018 Q3	–	Sell	-3,428	Closed	-$54K	–	1680
2018 Q2	$54K	Buy	+3,428	New	+$52.1K	﹤0.01%	978
2018 Q1	–	Sell	-1,842	Closed	-$21K	–	1645
2017 Q4	$21K	Buy	+1,842	New	+$20.6K	﹤0.01%	1068
2017 Q3	–	Sell	-4,696	Closed	-$53K	–	1537
2017 Q2	$53K	Buy	+4,696	New	+$86.8K	0.01%	897
2016 Q2	–	Sell	-7,910	Closed	-$193K	–	1492
2016 Q1	$193K	Buy	7,910 +6,125	+343%	+$142K	0.03%	544
2015 Q4	$58K	Buy	+1,785	New	+$60.4K	0.01%	772

Quantbot Technologies's ALDR Position: Q4 2019 in Review

Quantbot Technologies sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 300 shares — an estimated $5K sold.

Quantbot Technologies first reported a position in ALDR in Q4 2015 and held it in 6 quarters. The position peaked at $193K in Q1 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Quantbot Technologies reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Quantbot Technologies sold 300 Alder Biopharmaceuticals shares in Q4 2019, an estimated $5K.
Quantbot Technologies first reported a position in Alder Biopharmaceuticals in Q4 2015 and held it in 6 quarters.
Quantbot Technologies's Alder Biopharmaceuticals position peaked at $193K in Q1 2016.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Quantbot Technologies's 13F filing for Q4 2019, filed 10 Feb 2020.